Samsung Bioepis Holdings and Samsung Biologics to Start Trading on 24 November
​Samsung Biologics and Samsung Bioepis Holdings will start trading on 24 November with positive outlook due to improving operating leverage and...
476 Views
Samsung Biologics (207940 KS/Buy)Spin-Off Likely to Unlock Additional Value
We raise our target price for Samsung Biologics to W1,600,000 (from W1,400,000), which is based on the sum of the values of the CDMO business...
499 Views
Samsung Biologics (207940 KS): Momentum Accelerates in 3Q; Solid Order Book; Reaffirms FY Guidance
​Samsung Biologics reports strong revenue and profit growth in 3Q25, secures new contracts with global pharmaceutical partners, and aims to achieve...
499 Views
Biologics Spinco Filing: Posts Far More Aggressive Post-Listing Share Swap Lock-Up Than Expected
This post covers Samsung Biologics’ spinco filing, which imposes a far-tougher-than-expected post-listing share swap lock-up.
654 Views
Current Samsung Biologics Split Dynamics with Alpha Potential Both Ways
This post covers the current Samsung Biologics split dynamics, highlighting how the setup offers alpha potential in both directions
537 Views